C2N-8E12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C2N-8E12, covering 2017-07-26 to 2017-07-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy [Phase 1]